1. Home
  2. SLGL vs BRLT Comparison

SLGL vs BRLT Comparison

Compare SLGL & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • BRLT
  • Stock Information
  • Founded
  • SLGL 1997
  • BRLT 2005
  • Country
  • SLGL Israel
  • BRLT United States
  • Employees
  • SLGL N/A
  • BRLT N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • BRLT Consumer Specialties
  • Sector
  • SLGL Health Care
  • BRLT Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • BRLT Nasdaq
  • Market Cap
  • SLGL 21.1M
  • BRLT 21.8M
  • IPO Year
  • SLGL 2018
  • BRLT 2021
  • Fundamental
  • Price
  • SLGL $7.24
  • BRLT $1.41
  • Analyst Decision
  • SLGL Buy
  • BRLT Hold
  • Analyst Count
  • SLGL 1
  • BRLT 3
  • Target Price
  • SLGL $40.00
  • BRLT $1.80
  • AVG Volume (30 Days)
  • SLGL 13.2K
  • BRLT 59.8K
  • Earning Date
  • SLGL 05-23-2025
  • BRLT 05-06-2025
  • Dividend Yield
  • SLGL N/A
  • BRLT N/A
  • EPS Growth
  • SLGL N/A
  • BRLT N/A
  • EPS
  • SLGL N/A
  • BRLT N/A
  • Revenue
  • SLGL $12,103,000.00
  • BRLT $418,708,000.00
  • Revenue This Year
  • SLGL N/A
  • BRLT $3.79
  • Revenue Next Year
  • SLGL $31.17
  • BRLT $3.85
  • P/E Ratio
  • SLGL N/A
  • BRLT N/A
  • Revenue Growth
  • SLGL 603.66
  • BRLT N/A
  • 52 Week Low
  • SLGL $3.34
  • BRLT $1.25
  • 52 Week High
  • SLGL $16.50
  • BRLT $2.68
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 50.26
  • BRLT 45.92
  • Support Level
  • SLGL $7.15
  • BRLT $1.39
  • Resistance Level
  • SLGL $7.45
  • BRLT $1.49
  • Average True Range (ATR)
  • SLGL 0.32
  • BRLT 0.06
  • MACD
  • SLGL -0.10
  • BRLT 0.00
  • Stochastic Oscillator
  • SLGL 31.36
  • BRLT 53.57

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is a digitally native omnichannel jewelry company. The company designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. The sales of the company consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.

Share on Social Networks: